AAAAAA

   
Results: 1-9 |
Results: 9
RESULTS OF MDR-1 VECTOR MODIFICATION TRIAL INDICATE THAT GRANULOCYTE MACROPHAGE COLONY-FORMING UNIT CELLS DO NOT CONTRIBUTE TO POSTTRANSPLANT HEMATOPOIETIC RECOVERY FOLLOWING INTENSIVE SYSTEMIC THERAPY (VOL 93, PG 15346, 1996)/
Authors: HANANIA EG GILES RE KAVANAGH J FU SQ ELLERSON D ZU Z WANG T SU Y KUDELKA A RAHMAN Z HOLMES F HORTOBAGYI G CLAXTON D BACHIER C THALL P CHENG S HESTER J OSTROVE JM BIRD RE CHANG A KORBLING M SEONG D COTE R HOLZMAYER T MECHETNER E HEIMFELD S BERENSON R BURTNESS B EDWARDS C BAST B ANDREEFF M CHAMPLIN R DEISSEROTH AB
Citation: Eg. Hanania et al., RESULTS OF MDR-1 VECTOR MODIFICATION TRIAL INDICATE THAT GRANULOCYTE MACROPHAGE COLONY-FORMING UNIT CELLS DO NOT CONTRIBUTE TO POSTTRANSPLANT HEMATOPOIETIC RECOVERY FOLLOWING INTENSIVE SYSTEMIC THERAPY (VOL 93, PG 15346, 1996)/, Proceedings of the National Academy of Sciences of the United Statesof America, 94(10), 1997, pp. 5495-5495
AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) IN PATIENTS WITH FOLLICULAR NON-HODGKINS-LYMPHOMAS (FNHL) USING CD34+ SELECTION AND RETROVIRAL HEMATOPOIETIC TRANSDUCTION
Authors: BACHIER C GILES RE ELLERSON D HANANIA EG GARCIASANCHEZ F HALEY T CABANILLAS F CHAMPLIN R BERENSON R HEIMFELD S DEISSEROTH AB
Citation: C. Bachier et al., AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) IN PATIENTS WITH FOLLICULAR NON-HODGKINS-LYMPHOMAS (FNHL) USING CD34+ SELECTION AND RETROVIRAL HEMATOPOIETIC TRANSDUCTION, Journal of investigative medicine, 44(3), 1996, pp. 279-279
THE HUMAN MULTIPLE-DRUG RESISTANCE GENE (MDR-1) IS USED TO CONFER CHEMOPROTECTION UPON HEMATOPOIETIC PROGENITOR CELLS IN A CLINICAL GENE-THERAPY TRIAL SETTING FOR OVARIAN AND BREAST-CANCER-TREATMENT
Authors: HANANIA EG GILES RE KAVANAGH J ELLERSON D WANG T ZU Z CALVERT L HALEY T HAMER J BERENSON R HEIMFELD S RAHMAN Z CHAMPLIN R DEISSEROTH AB
Citation: Eg. Hanania et al., THE HUMAN MULTIPLE-DRUG RESISTANCE GENE (MDR-1) IS USED TO CONFER CHEMOPROTECTION UPON HEMATOPOIETIC PROGENITOR CELLS IN A CLINICAL GENE-THERAPY TRIAL SETTING FOR OVARIAN AND BREAST-CANCER-TREATMENT, Journal of investigative medicine, 44(3), 1996, pp. 314-314
RESULTS OF MDR-1 VECTOR MODIFICATION TRIAL INDICATE THAT GRANULOCYTE MACROPHAGE COLONY-FORMING UNIT CELLS DO NOT CONTRIBUTE TO POSTTRANSPLANT HEMATOPOIETIC RECOVERY FOLLOWING INTENSIVE SYSTEMIC THERAPY/
Authors: HANANIA EG GILES RE KAVANAGH J ELLERSON D ZU Z WANG T SU Y KUDELKA A RAHMAN Z HOLMES F HORTOBAGYI G CLAXTON D BACHIER C THALL P CHENG S HESTER J OSTROVE JM BIRD RE CHANG A KORBLING M SEONG D COTE R HOLZMAYER T MECHETNER E HEIMFELD S BERENSON R BURTNESS B EDWARDS C BAST R ANDREEFF M CHAMPLIN R DEISSEROTH AB
Citation: Eg. Hanania et al., RESULTS OF MDR-1 VECTOR MODIFICATION TRIAL INDICATE THAT GRANULOCYTE MACROPHAGE COLONY-FORMING UNIT CELLS DO NOT CONTRIBUTE TO POSTTRANSPLANT HEMATOPOIETIC RECOVERY FOLLOWING INTENSIVE SYSTEMIC THERAPY/, Proceedings of the National Academy of Sciences of the United Statesof America, 93(26), 1996, pp. 15346-15351
RETROVIRAL GENE MARKING TO IDENTIFY THE ORIGIN OF RELAPSE FOLLOWING AUTOLOGOUS CD34 POSITIVE BONE-MARROW (BM) AND PERIPHERAL-BLOOD (PB) TRANSPLANTATION IN FOLLICULAR NONHODGKINS LYMPHOMA (FNHL)
Authors: BACHIER C GILES RE ELLERSON D HANANIA EG GARCIASANCHEZ F HALEY T ANDREEFF M CABANILLAS F CHAMPLIN R BERENSON R HEIMFELD S DEISSEROTH AB
Citation: C. Bachier et al., RETROVIRAL GENE MARKING TO IDENTIFY THE ORIGIN OF RELAPSE FOLLOWING AUTOLOGOUS CD34 POSITIVE BONE-MARROW (BM) AND PERIPHERAL-BLOOD (PB) TRANSPLANTATION IN FOLLICULAR NONHODGKINS LYMPHOMA (FNHL), Blood, 88(10), 1996, pp. 1707-1707
CHEMOTHERAPY RESISTANCE TO TAXOL IN CLONOGENIC PROGENITOR CELLS FOLLOWING TRANSDUCTION OF CD34 SELECTED MARROW AND PERIPHERAL-BLOOD CELLS WITH A RETROVIRUS THAT CONTAINS THE MDR-1 CHEMOTHERAPY RESISTANCE GENE
Authors: HANANIA EG FU S ZU Z HEGEWISCHBECKER S KORBLING M HESTER J DURETT A ANDREEFF M MECHETNER E HOLZMAYER T RONINSON IB GILES RE BERENSON R HEIMFELD S DEISSEROTH AB
Citation: Eg. Hanania et al., CHEMOTHERAPY RESISTANCE TO TAXOL IN CLONOGENIC PROGENITOR CELLS FOLLOWING TRANSDUCTION OF CD34 SELECTED MARROW AND PERIPHERAL-BLOOD CELLS WITH A RETROVIRUS THAT CONTAINS THE MDR-1 CHEMOTHERAPY RESISTANCE GENE, Gene therapy, 2(4), 1995, pp. 285-294
PREPARATION AND CHARACTERIZATION OF RECOMBINANT DNA-DERIVED OVINE GROWTH-HORMONE VARIANTS IN WHICH THE C-TERMINAL DISULFIDE BRIDGE IS MODIFIED
Authors: GILES RE WALLIS OC WALLIS M
Citation: Re. Giles et al., PREPARATION AND CHARACTERIZATION OF RECOMBINANT DNA-DERIVED OVINE GROWTH-HORMONE VARIANTS IN WHICH THE C-TERMINAL DISULFIDE BRIDGE IS MODIFIED, Biochemical Society transactions, 23(2), 1995, pp. 220-220
RAPID NEUTROPHIL RECOVERY IN AUTOLOGOUS TRANSPLANTS USING CELLS THAT HAVE BEEN EXPOSED TO A MULTIPLE-DRUG RESISTANCE (MDR-1) RETROVIRAL VECTOR
Authors: HANANIA EG KAVANAGH J GILES RE KUDELKA A RAHMAN Z HOLMES F HORTOBAGYI G HAMER J CALVERT L FINNEGAN MB MANTE R ELLERSON D GEISLER D WANG T SU Y ZU Z CHEN N BERENSON R HEIMFELD S CLAXTON D MECHETNER E HOLZMAYER T MEHRA R COTE R CHAMPLIN R DEISSEROTH AB
Citation: Eg. Hanania et al., RAPID NEUTROPHIL RECOVERY IN AUTOLOGOUS TRANSPLANTS USING CELLS THAT HAVE BEEN EXPOSED TO A MULTIPLE-DRUG RESISTANCE (MDR-1) RETROVIRAL VECTOR, Blood, 86(10), 1995, pp. 1833-1833
RECENT ADVANCES IN THE APPLICATION OF GENE-THERAPY TO HUMAN-DISEASE
Authors: HANANIA EG KAVANAGH J HORTOBAGYI G GILES RE CHAMPLIN R DEISSEROTH AB
Citation: Eg. Hanania et al., RECENT ADVANCES IN THE APPLICATION OF GENE-THERAPY TO HUMAN-DISEASE, The American journal of medicine, 99(5), 1995, pp. 537-552
Risultati: 1-9 |